Enzon Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net income was USD 1.37 million compared to net loss of USD 0.186 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0834 USD | -5.17% | +15.33% | -10.79% |
1st Jan change | Capi. | |
---|---|---|
-10.79% | 6.19M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ENZN Stock
- News Enzon Pharmaceuticals, Inc.
- Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023